Deciphering Drug Mechanisms

© 2004 AAASThese sample data illustrate how phenotypic profiles can be used to tease out novel drug mechanisms.A team of Harvard scientists has found a high-throughput way to tie drugs with the cellular functions they affect.1 Comparing the profiles of uncharacterized compounds with those of well-studied ones, the group also predicted modes of action. The study employed a combination of fluorescent probes, high-throughput microscopy, automated image analysis, and advanced statistics."We hav

Written byLinda Sage
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

© 2004 AAAS

These sample data illustrate how phenotypic profiles can be used to tease out novel drug mechanisms.

A team of Harvard scientists has found a high-throughput way to tie drugs with the cellular functions they affect.1 Comparing the profiles of uncharacterized compounds with those of well-studied ones, the group also predicted modes of action. The study employed a combination of fluorescent probes, high-throughput microscopy, automated image analysis, and advanced statistics.

"We have been able to relate really complicated and drug-dependent phenotypes to mechanism based on direct readout from individual cells," says team member Steven Altschuler, research fellow at Harvard's Bauer Center for Genomics Research.

The researchers placed HeLa cells in 384-well plates and incubated each well with one of 100 drugs at 13 different concentrations. After 20 hours, they treated the cells with a DNA probe to locate nuclei and two different fluorescent antibodies, and then imaged the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies